Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
ContributorsD'Addario, G.; Rauch, D.; Stupp, R.; Pless, M.; Stahel, R.; Mach, Nicolas; Jost, L.; Widmer, L.; Tapia, C.; Bihl, M.; Mayer, M.; Ribi, K.; Lerch, S.; Bubendorf, L.; Betticher, D.C.
Published inAnnals of oncology, vol. 19, no. 4, p. 739-745
Publication date2008-04
Abstract
Keywords
- Advanced disease
- Chemotherapy
- First-line therapy
- Gefitinib
- Non-small-cell lung cancer
Affiliation
Research group
Citation (ISO format)
D’ADDARIO, G. et al. Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. In: Annals of oncology, 2008, vol. 19, n° 4, p. 739–745. doi: 10.1093/annonc/mdm564
Main files (1)
Article (Published version)
Identifiers
- PID : unige:161378
- DOI : 10.1093/annonc/mdm564
- PMID : 18096565
ISSN of the journal0923-7534